Effects of Varenicline on Cigarette Self Administration

Completed · Phase 2 · Has a placebo group

Conditions studied: Nicotine Dependence

In brief

The investigators hypothesize that varenicline will dose dependently attenuate the subjective effects of cigarettes after a period of abstinence. Also, treatment with varenicline will dose dependently weaken the severity of nicotine withdrawal symptoms. Thirdly, we hypothesize that treatment with varenicline will dose dependently decrease cigarette self-administration in the model proposed.

Key facts

Study ID
NCT00731055
Run by
New York State Psychiatric Institute
People needed
16
Starts
2008-02-01
Expected to finish
2009-05-01
Last updated by the study team
2018-06-18

Who can join

Age: 21 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.